The CEO's $1.24M open-market purchase is a strong conviction signal, especially given KURA's 86% analyst bullish consensus and prior positive T+20 performance on bullish reports (+5.25% avg). Monitor for near-term catalysts such as pipeline updates or partnership announcements that may have motivated the insider buying. The selling by legal and commercial officers is likely liquidity-driven and does not offset the CEO's signal.
Price Chart
Executive Summary
Kura Oncology CEO Troy Wilson purchased $1.24M in open-market shares at ~$12.39, while the Chief Legal Officer and Chief Commercial Officer sold a combined ~$449K. The CEO's buy is a strong bullish signal at ~0.11% of market cap, partially offset by routine insider selling from non-C-suite officers. The cluster is mixed in net direction but the CEO's conviction purchase dominates in both dollar value and seniority.
Key Financial Metrics
Key Facts
- CEO Troy Wilson purchased 100,000 shares for $1.24M in open-market transaction at $12.39/share
- Chief Legal Officer Teresa Bair sold 31,487 shares for $398K at $12.63
- Chief Commercial Officer Brian Powl sold 4,345 shares for $52K at $11.89
- Total insider cluster value: $1.69M ($1.24M buys, $449K sells)
- CEO buy represents ~0.11% of KURA's $1.1B market cap
Financial Impact
CEO purchase of $1.24M is material relative to typical insider activity; selling by two officers totals $449K, which is routine for a $1.1B market cap company
Risk Factors
- Insider selling by two senior officers could indicate internal concerns about near-term valuation
- Biotech sector volatility could overshadow insider signal
- CEO purchase at $12.39 is below recent levels; stock could face resistance
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-KURA-1787645134838 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 9, 2026 23d ago | 8-K | $12.09 $11.37 | ▼ −6.00% | ▼ −5.66% | $10.65 (−11.91%) |
Sep 8, 2026 24d ago | 8-K | $12.52 $11.30 | ▼ −9.74% | ▼ −8.63% | $10.65 (−14.94%) |
Aug 24, 2026 5w ago | Insider Cluster | $12.40 $12.65 | ▲ +2.02% | ▲ +1.55% | $10.65 (−14.11%) |
Aug 21, 2026 6w ago | Insider Cluster | $11.89 $12.66 | ▲ +6.48% | ▲ +6.00% | $10.65 (−10.43%) |
Aug 17, 2026 6w ago | Insider Buy | $12.33 $13.59 | ▲ +10.22% | ▲ +10.42% | $10.65 (−13.63%) |
Aug 12, 2026 7w ago | Press Release | $10.09 $11.71 | ▲ +16.06% | ▲ +18.02% | $10.65 (+5.55%) |
Aug 5, 2026 8w ago | Press Release | $9.20 $9.94 | ▲ +8.04% | ▲ +7.69% | $10.65 (+15.76%) |
Jul 29, 2026 9w ago | 8-K | $9.31 $9.28 | ▼ −0.32% | ▼ −3.94% | $10.65 (+14.39%) |
Jul 14, 2026 11w ago | Press Release | $11.24 $10.68 | ▼ −4.98% | ▼ −3.69% | $10.65 (−5.25%) |
Jun 3, 2026 17w ago | Press Release | $8.66 $8.68 | ▲ +0.29% | ▲ +4.11% | $10.65 (+23.05%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access